French Patients Demand Medical Cannabis Access as Regulatory Delays Jeopardize 2027 Timeline

French patient advocacy groups are calling on the government to accelerate medical cannabis access expansion, citing significant delays that threaten the planned 2027 implementation timeline. Currently, only patients enrolled in the original clinical trial program maintain their medical cannabis treatments, while new patient enrollment remains blocked. The temporary regulatory framework has stalled progress, prompting organizations to demand the government complete comprehensive regulations and establish concrete timelines for broader access. These delays particularly affect patients with chronic conditions who could benefit from cannabis-based therapeutics while waiting for formal approval pathways.